Evidence map›Paper›PMID 38912775›Full record

ArticlemBio2024

A

John Kane, Xue Li, Sudhir Kumar, Katrina A Button-Simons, Katelyn M Vendrely Brenneman, Haley Dahlhoff, Mackenzie A C Sievert, Lisa A Checkley, Douglas A Shoue, Puspendra P Singh and 15 more

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. A Multidimensional Analysis of the Bimodal Piperaquine Response inbioRxiv : the preprint server for biology · 2026
    Article
  4. AbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Changing genetic profiles ofAntimicrobial agents and chemotherapy · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Temporal and spatial dynamics ofbioRxiv : the preprint server for biology · 2024
    Article
  15. IncompleteFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

  • Update of
    A2023
5 · Who and what money

Authors and funding

25 authors.

John KaneDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0003-4917-7205
Xue LiDisease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Sudhir KumarCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.ORCID 0000-0002-2847-393X
Katrina A Button-SimonsDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Katelyn M Vendrely BrennemanDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Haley DahlhoffDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Mackenzie A C SievertDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Lisa A CheckleyDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Douglas A ShoueDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Puspendra P SinghDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Biley A AbatiyowCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Meseret T HaileCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Shalini NairDisease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Ann ReyesDisease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Rupam TripuraMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Thomas J PetoMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Dysoley LekNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Angana MukherjeeDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Mehul DhordaMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Standwell C NkhomaBEI Resources, American Type Culture Collection (ATCC), Manassas, Virginia, USA.
Ian H CheesemanHost Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Ashley M VaughanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Timothy J C AndersonDisease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.ORCID 0000-0002-0191-0204
Michael T FerdigDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0003-3516-9829

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Systems genetics of artemisinin resistanceP01AI127338 · NIAID · UNIVERSITY OF NOTRE DAME · PI Michael T Ferdig, Ashley M Vaughan · 2017 to 2026
$21.3M
MAPPING DRUG RESISTANCE GENES IN PLASMODIUM FALCIPARUMR01AI048071 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Tim J Anderson · 2000 to 2026
$8.4M
Mapping Drug Resistance Genes in Plasmodium falciparumR37AI048071 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI ANDERSON, TIM J · 2012 to 2021
$7.9M
MOLECULAR AND BIOCHEMICAL GENETICS LABORATORY RENOVATIONC06RR013556 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 1998 to 1998
–
HHS | National Institutes of Health (NIH) AI048071HHS | National Institutes of Health (NIH) AI127338NCRR NIH HHS C06 RR013556NIAID NIH HHS P01 AI127338NIAID NIH HHS R01 AI048071NIAID NIH HHS R37 AI048071NIH HHS P51 OD011133Texas Biomedical Research Institute (Texas Biomed) 20-04866Wellcome TrustWellcome Trust of Great Britain 099992/Z/12/Z
6 · The paper itself

Abstract

Piperaquine (PPQ) is widely used in combination with dihydroartemisinin as a first-line treatment against malaria. Multiple genetic drivers of PPQ resistance have been reported, including mutations in the

Indexed as

AntimalarialsAspartic Acid EndopeptidasesDrug ResistanceMembrane Transport ProteinsPlasmodium falciparumProtozoan ProteinsQuinolinesAllelesCambodiaHumansMalaria, FalciparumMutationPiperazinesAntimalarialsAspartic Acid EndopeptidasesMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumpiperaquinePiperazinesplasmepsinplasmepsin IIProtozoan ProteinsQuinolinesdrug resistance evolutiongenetic crossmalariapiperaquinePlasmodium falciparum

Identifiers

PMID38912775
PMCPMC11253641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.